A single-institution phase II study indicated that combination chemotherapy using UFT (tegafur and uracil) plus cisplatin (Platinol) in patients with non-small-cell lung cancer was active with less host toxicity than other cisplatin-
Hisanobu Niitani, MD
Advertisement
Articles by Hisanobu Niitani, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
2
Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review
3
FDA Delays Decision on Subcutaneous Isatuximab in Multiple Myeloma
4
3 Things You Should Know About TROP2-Directed Antibody-Drug Conjugates in the Frontline Treatment of Metastatic Triple-Negative Breast Cancer
5